ADVERTISEMENT
ADVERTISEMENT
Scientists Criticize Mouse Study of New Alzheimer’s Drug
Scientists Criticize Mouse Study of New Alzheimer’s Drug
Oligomannate, recently approved in China, is being met with some skepticism from researchers.
Scientists Criticize Mouse Study of New Alzheimer’s Drug
Scientists Criticize Mouse Study of New Alzheimer’s Drug

Oligomannate, recently approved in China, is being met with some skepticism from researchers.

Oligomannate, recently approved in China, is being met with some skepticism from researchers.

  1. Home
  2. Subjects
  3. oligomannate

oligomannate

oligomannate alzheimer's disease neurodegeneration microbiome seaweed drug approval china
China Approves Alzheimer’s Treatment that Targets the Microbiome
Kerry Grens | Nov 5, 2019 | 2 min read
Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.
ADVERTISEMENT
ADVERTISEMENT